(LEAD) Regulator begins review of suspected accounting breaches at Samsung BioLogics
(ATTN: ADDS stock reaction in last para)
SEOUL, May 17 (Yonhap) -- The financial authorities and Samsung BioLogics Co. on Thursday held their first session reviewing a regulatory probe into the biotechnology firm over suspected accounting breaches, of